Table 2. Results of meta-analysis of postoperative complications.
Outcomes | No. of studies | No. of patients | Heterogeneity | Merge analysis | |||
---|---|---|---|---|---|---|---|
Chi2 | I2(%) | Pvalue | OR (95% CI) | P value | |||
Overall complications | 7 | 518/516 | 6.56 | 9 | 0.36 | 1.52 (1.14–2.04) | 0.005 |
Minor complications | 5 | 344/357 | 4.72 | 15 | 0.32 | 1.84 (1.27–2.66) | 0.001 |
Major complications | 2 | 130/130 | 2.84 | 65 | 0.09 | 0.54 (0.04–7.16) | 0.64 |
Specific adverse events | |||||||
Urinary retention | 6 | 493/491 | 2.44 | 0 | 0.79 | 1.80 (1.02–3.16) | 0.04 |
Capsular perforation | 3 | 210/250 | 0.59 | 0 | 0.75 | 0.52 (0.20–1.37) | 0.18 |
Dysuria | 3 | 248/273 | 0.20 | 0 | 0.90 | 1.16 (0.67–2.00) | 0.59 |
Re-treatment | 4 | 363/361 | 1.14 | 0 | 0.77 | 2.36 (0.68–8.19) | 0.17 |
Bladder neck contracture | 2 | 138/123 | 1.20 | 17 | 0.27 | 0.64 (0.12–3.35) | 0.60 |
Urethral stenosis | 2 | 138/123 | 0.77 | 0 | 0.38 | 0.91 (0.12–6.68) | 0.93 |
Notes.
- No.
- number
- /
- 120 W HPS versus 180 W XPS
- Chi2
- Chi-square test value
- I2
- I-squared test value
- OR
- odds ratios
- 95% CI
- 95% confidence interval